{"id":"W2095647706","doi":"10.1016/s0140-6736(10)61194-4","title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1010,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Eisai; Daiichi-Sankyo; Daiichi Sankyo Europe; Boehringer Ingelheim","keywords":"Warfarin; Dabigatran; Medicine; Atrial fibrillation; Quartile; Stroke (engine); Internal medicine; Randomized controlled trial; Population; Anesthesia; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07215357664148973,"score_gpt":0.3455962858138768,"score_spread":0.2734427091723871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}